See-Mode Technologies Receives Health Canada Approval for AI Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans – Yahoo Finance
MELBOURNE, Australia, Nov. 17, 2022 /CNW/ — See-Mode Technologies, a MedTech company based in Australia that is on a mission to unlock the hidden insights within medical imaging, today announced that it has received approval from Health Canada for its product expansion to support Breast & Thyroid ultrasound examinations.
See-Mode uses Artificial Intelligence to detect lesions in ultrasound images, then assigns feature classifications to each lesion, in line with the American College of Radiology’s BI-RADS and TI-RADS rating systems. Sonographer worksheets, complete with lesion classifications and diagrams are instantly generated and sent to PACS, while preliminary impressions are sent to radiology reporting systems. In follow-up scans, See-Mode allows for fast comparison between old and new images, and will automatically highlight changes in lesion characteristics.
“Receiving approval from Health Canada is a significant step forward for us at See-Mode, which demonstrates the applicability of our software beyond the vascular studies we currently support”, said Dr Milad Mohammadzadeh, Co-Founder and Director, See-Mode Technologies. “Working closely with clinicians we learned that the reporting of Breast & Thyroid examinations was notoriously time consuming, subjective, and error prone, especially when there are multiple lesions present. We are excited to enable clinicians across Canada to complete their reports more efficiently and provide a second set of eyes on the study making sure nothing is missed.”
“See-Mode represents a tremendous step forward by combining the power of Artificial Intelligence with the expertise of a clinical sonographer and radiologist. See-Mode eliminates tedious manual steps in the interpretation and reporting of ultrasound images, improves efficiency and provides unparalleled consistency of reporting between different members of the radiology team. This is a system that truly understands the content of ultrasound images.” Martin Necas, Specialist Sonographer, Waikato Hospital, Clinical Consultant for See-Mode.
Studies conducted by See-Mode determined there were large inconsistencies in describing the characteristics of nodules and lesions by sonographers. For Thyroid studies, See-Mode has the potential to reduce unnecessary biopsies and improve the accuracy of the biopsies that are performed. With Breast ultrasound examinations, See-Mode assists clinicians to detect malignancy that may otherwise go undiscovered or misclassified.
About See-Mode Technologies
See-Mode applies cutting-edge deep learning and computational modeling techniques on medical images to empower clinicians to improve their clinical workflow and patient outcomes. See-Mode’s first product, AVA, automatically analyses and reports on vascular ultrasound studies. AVA is currently clinically live across the US, Australia, Singapore, and New Zealand. See-Mode has offices in Singapore and Australia and is backed by prominent venture capital firms in APAC, including MassMutual Ventures, Blackbird Ventures, Cocoon Capital, and SGInnovate.
View original content to download multimedia:https://www.prnewswire.com/news-releases/see-mode-technologies-receives-health-canada-approval-for-ai-software-that-automatically-analyses-and-reports-breast–thyroid-ultrasound-scans-301679574.html
SOURCE See-Mode Technologies
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2022/17/c4453.html
Radiotherapy does not improve long-term survival rates for breast cancer patients, new research suggests.
A brain tumour vaccine doubles the five-year survival rate for cancer patients, a trial has shown, in the first major breakthrough for decades.
Krystal Biotech Inc's (NASDAQ: KRYS) subsidiary Jeune Aesthetics Inc, announced nine-month durability of effect in the extension cohort of the PEARL-1 study of KB301 to address the underlying biology of aging skin for improvement of fine lines and wrinkles. Ten subjects from the PEARL-1 efficacy cohort were enrolled in the PEARL-1 extension cohort, an open-label study to assess the duration of effect below the zygomatic arch (the lower cheek area). The extension cohort enrolled subjects who had
Transcranial magnetic stimulation has worked when medication and other therapies have not. Monty Rakusen/Image Source via Getty ImagesNot only is depression a debilitating disease, but it is also widespread. Approximately 20 million adult Americans experience at least one episode of depression per year. Millions of them take medication to treat their depression. But for many, the medications don’t work: Either they have minimal or no effect, or the side effects are intolerable. These patients ha
Bitcoin (BTC) is trading steadily at the $16,000 level as inflation shows signs of easing. Opimas CEO and founder Octavio Marenzi joins “First Mover” to discuss whether bitcoin has hit bottom following FTX’s collapse and which players could benefit from the crypto exchange’s fallout.
‘Confusing, and long, and drawn-out.’ Some hospitals make getting aid hard, delay checking eligibility and sometimes press for payments that aren’t refunded even if a patient eventually gets qualified for assistance.
Children's Place Inc (NASDAQ: PLCE) reported a third-quarter FY22 sales decline of 8.8% year-on-year to $509.12 million, beating the consensus of $499.44 million. Comparable retail sales decreased 10% for the quarter. The decrease in sales was primarily due to permanent store closures and a slowdown in consumer demand resulting from the unprecedented inflation impacting its customers. The gross profit decreased 27.7% Y/Y to $176.9 million, with the margin contracting 910 basis points to 34.7%. T
Micron stock is fading on a bearish update from the company. However, there are a few layers of support to keep an eye on.
A leading cryptocurrency retail service provider in Hong Kong said it has ceased trading as the broader fallout from the collapse of FTX, and solvency issues at other major crypto firms, continues to roil the sector. Genesis Block, which at one time operated one of Asia's biggest bitcoin ATM networks, said it would be closing down its over-the-counter trading portal on Dec. 10, according to an email to customers sent by its compliance department reviewed by Reuters. Genesis Block has no connection with a separate crypto player called Genesis Global Capital which suspended customer redemptions this week.
REE Automotive Ltd (NASDAQ: REE) reported a third-quarter FY22 net loss of $(33.5) million versus a net loss of $(414.9) million the previous year. The decrease in GAAP net loss Y/Y is mainly attributed to lower share-based compensation expenses. The company's loss widened from $(25.2) million in 2Q22, driven by lower income from the remeasurement of warrants and increased operating expenses, including transaction costs. Non-GAAP EPS loss of $(0.09), beat the consensus of $(0.10). The non-GAAP o
Jeff Zadoks, Post’s finance chief since 2014, will continue with the company as chief operating officer.
Discover four of the best-performing mutual funds managed and administered by Franklin Templeton Investments that invest in equities and fixed income securities.
While constant growth in the company's fleet is aiding Air Lease (AL), rising operating expenses might weigh on its bottom line.
CEO Jonathan Akeroyd is ready to shift the brand into high gear, ramping up accessories and minting bestsellers courtesy of designer Daniel Lee.
Crypto investment bank Genesis Global Trading said in a tweet it was temporarily suspending redemptions and new loan originations in the wake of FTX's collapse, which has given cryptocurrencies another hammering this year. Genesis, the latest company to be hit by FTX turmoil, is owned by Digital Currency Group (DCG), which is also the parent company of Grayscale. Grayscale said it would be business as usual for its products and its underlying assets were unaffected.
TJX Companies Inc (NYSE: TJX) reported a third-quarter FY23 sales decline of 3% year-on-year to $12.17 billion, missing the consensus of $12.30 billion. The U.S. comparable store sales decreased 2% versus last year, with Marmaxx store sales increasing 3% and HomeGoods declining 16%. The gross profit margin for the quarter contracted 40 basis points to 29.1%. Selling, general and administrative expenses fell 4.9% to $2.2 billion. The company held $3.4 billion in cash and equivalents as of October
MF Bond Report for VWIUX
The Swiss arm of Credit Suisse's investment bank will be largely unaffected by the restructuring plan the bank announced last month, said Jens Haas, head of investment banking Switzerland. "We will retain our full footprint here in Switzerland, so from a client perspective and a market perspective, certainly nothing will change," he told Swiss newspaper L'Agefi. Along with a 4 billion Swiss franc ($4.2 billion) capital raise and thousands of job cuts, Credit Suisse is planning to scale back its scandal-hit investment bank in a shift towards banking for the wealthy.
On Wednesday, Granite Construction got an upgrade to its Relative Strength (RS) Rating, from 70 to 84. It's a milestone movement because market research shows that the best stocks tend to have an RS Rating north of 80 as they launch their biggest runs. Wednesday afternoon, Granite Construction stock was down about 1% at 34.81 in sync with market consolidation.
Here are the money market accounts that made our top 10 based on their APY, minimum opening deposit, maintenance fees, and customer service options.